What is Clinisys Associates?
Operating out of Atlanta, Georgia, for nearly 25 years, Clinisys Associates has transitioned from a boutique operation into a cornerstone provider for the biomedical supply community. The company specializes in the procurement and distribution of rare blood products, hemostasis components, and pre-tested plasma samples essential for advanced medical research. By maintaining a rigorous standard of quality control and facilitating rapid, worldwide logistics, Clinisys serves as a vital link between biological resource repositories and the clinical research institutions that rely on them for life-saving innovation. Their market position is defined by a deep-seated expertise in handling sensitive biological materials, ensuring that medical professionals receive consistent, high-value components for their diagnostic and therapeutic workflows.
How much funding has Clinisys Associates raised?
Clinisys Associates has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2021): $150K with participation from PPP
Key Investors in Clinisys Associates
PPP
Public-Private Partnership
What's next for Clinisys Associates?
With this recent strategic investment, Clinisys Associates is well-positioned to accelerate its growth initiatives within the competitive life sciences landscape. The company is expected to leverage this capital to modernize its facility infrastructure and expand its global reach, potentially diversifying its portfolio of rare blood products to meet the evolving demands of the biomedical sector. As the firm moves into this next phase of development, the focus will likely remain on optimizing supply chain resilience and deepening its integration with international research networks. By prioritizing operational efficiency and maintaining its reputation for specialized service, Clinisys is poised to capture additional market share while continuing to support the critical needs of the global medical community.
See full Clinisys Associates company page
